BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer
Milan, September 22, 2025 (GlobeNewsire) – BetaGlue® Therapeutics (“BetaGlue” or the “Company”) a clinical-stage oncology company developing an innovative radiotherapy platform for the targeted and personalised treatment of unresectable solid…
Read more








